SLI
1.967,05
PKT
-34,53
PKT
-1,73
%
Werbung
Analysen zu SLI-Werten
Datum | Rating | Analyst | |
---|---|---|---|
25.03.21 | Holcim Hold | Jefferies & Company Inc. | |
25.03.21 | UBS Outperform | Credit Suisse Group | |
24.03.21 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
24.03.21 | Roche overweight | Barclays Capital | |
24.03.21 | Roche Neutral | JP Morgan Chase & Co. | |
24.03.21 | Roche Conviction Buy | Goldman Sachs Group Inc. | |
23.03.21 | Roche Neutral | JP Morgan Chase & Co. | |
23.03.21 | Novartis Underweight | JP Morgan Chase & Co. | |
23.03.21 | Novartis buy | Jefferies & Company Inc. | |
23.03.21 | Novartis market-perform | Bernstein Research | |
23.03.21 | Roche Outperform | Bernstein Research | |
23.03.21 | UBS kaufen | DZ BANK | |
23.03.21 | Roche Neutral | UBS AG | |
23.03.21 | Roche Hold | Deutsche Bank AG | |
23.03.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
23.03.21 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
22.03.21 | Roche overweight | Barclays Capital | |
22.03.21 | Novartis market-perform | Bernstein Research | |
22.03.21 | Roche Neutral | UBS AG | |
22.03.21 | Roche Conviction Buy | Goldman Sachs Group Inc. | |
22.03.21 | Roche Neutral | JP Morgan Chase & Co. | |
19.03.21 | Holcim overweight | JP Morgan Chase & Co. | |
18.03.21 | UBS overweight | JP Morgan Chase & Co. | |
18.03.21 | Nestlé overweight | JP Morgan Chase & Co. | |
17.03.21 | UBS Neutral | UBS AG | |
17.03.21 | UBS Hold | Kepler Cheuvreux | |
17.03.21 | Nestlé overweight | Morgan Stanley | |
17.03.21 | Swiss Re overweight | JP Morgan Chase & Co. | |
16.03.21 | UBS Outperform | Credit Suisse Group | |
16.03.21 | UBS Sector Perform | RBC Capital Markets | |
16.03.21 | UBS overweight | JP Morgan Chase & Co. | |
16.03.21 | Roche Hold | Jefferies & Company Inc. | |
15.03.21 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
15.03.21 | Roche Neutral | UBS AG | |
12.03.21 | Swiss Re overweight | Barclays Capital | |
12.03.21 | ams-OSRAM Underweight | Barclays Capital | |
12.03.21 | UBS Neutral | Goldman Sachs Group Inc. | |
11.03.21 | Givaudan Underperform | Bernstein Research | |
11.03.21 | ams-OSRAM Outperform | Credit Suisse Group | |
10.03.21 | Novartis buy | Deutsche Bank AG |